Cmg Pharmaceutical Co., Ltd. (058820) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cmg Pharmaceutical Co., Ltd. (058820:KRX), powered by AI.

Current Price
₩1,122
P/E Ratio
-16.5
Market Cap
165.9B
Sector
Healthcare
What is the Cmg Pharmaceutical Co., Ltd. stock price forecast?

Cmg Pharmaceutical Co., Ltd. is currently trading at ₩1,122. View real-time AI analysis on Alpha Lenz.

What is Cmg Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Cmg Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Cmg Pharmaceutical Co., Ltd.'s P/E ratio?

Cmg Pharmaceutical Co., Ltd.'s P/E ratio is -16.5.

Cmg Pharmaceutical Co., Ltd.

KRX · 058820
₩1,122+0(+0.00%)Market closedKRX regular session 09:00–15:30 KST
Ask about Cmg Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Cmg Pharmaceutical Co., Ltd. trades at a P/E of -16.5 (undervalued) with modest ROE of -5.2%.

Ask for details

Company Overview

Cmg Pharmaceutical Co., Ltd. is a company engaged in the development, production, and distribution of pharmaceutical products. Its primary function is to create medical solutions that address various health conditions, contributing to the broader healthcare and life sciences sectors. The company focuses on producing innovative and effective medications that meet high regulatory standards, ensuring safety and efficacy for consumers. Specializing in areas such as biosimilars, generic drugs, and proprietary pharmaceuticals, Cmg Pharmaceutical Co., Ltd. plays a critical role in increasing access to essential medicines and reducing healthcare costs. Its activities support the dynamic pharmaceutical market by advancing medical research and expanding treatment options. Headquartered in South Korea, the company extends its reach through international partnerships, catering to a global clientele. Through its commitment to research and development, Cmg Pharmaceutical Co., Ltd. remains a key player in driving the evolution of healthcare solutions worldwide.

CEO이주형
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees229

Company Statistics

FY 2025

Profile

₩165,878,929,326Market Cap
₩105,229,184,680Revenue
147.84MShares Out
229Employees

Margins

57.91%Gross
-0.41%EBITDA
-3.51%Operating
-11.25%Pre-Tax
-9.58%Net

Valuation

-16.46P/E
0.82P/B
1.58EV/Sales
-538.83EV/EBITDA
-3.77P/FCF

Growth (CAGR)

8.58%Rev 3Yr
10.30%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-3.31%ROA
-5.15%ROE
-2.85%ROIC

Financial Health

₩6,122,827,000Cash & Cash Equivalents
₩98,283,963,260Net Debt
51.80%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Cmg Pharmaceutical Co., Ltd. (ticker: 058820) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 229 employees. Market cap is $165.9B.

The current price is ₩1,122 with a P/E ratio of -16.46x and P/B of 0.82x.

ROE is -5.15% and operating margin is -3.51%. Annual revenue is $105.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Cmg Pharmaceutical Co., Ltd. (058820) Stock Forecast 2026 ₩1,122 — Price, Financials & Analyst Targets | Alpha Lenz